FSD Pharma Announces Launch of IBS Clinical Study

beaker art

CANADA: FSD Pharma has announced the launch of a pilot clinical study in Pittsburgh, Pennsylvania, by its strategic R&D partner, SciCann Therapeutics. The study is designed to test the safety and efficacy of SciCann’s proprietary “Steady Stomach” cannabidiol (CBD) combination product for the treatment of irritable bowel syndrome (IBS) patients. This study follows the previously reported efficacy Read the full article…

OLCC Marks To Address MMJ Regulatory Changes At ICBC

Steve Marks on stage at CCC

OREGON: Oregon Liquor Control Commission Executive Director Steve Marks will provide an overview of the agency’s medical marijuana tracking program and an outlook on the steps the agency is taking to balance its regulatory responsibilities while accommodating the needs of medical marijuana patients in a keynote address at the International Cannabis and Business Conference. The OLCC began Read the full article…

iCAN Signs MoU With Yom Chai for Crohn’s Disease And Autism

the wide world of weed

ISRAEL: The Directors of Ananda Developments have announced that investee company iCAN has signed an MoU with a new Israeli Medical Cannabis company Yom Chai to develop and clinically validate cannabis based treatments for Crohn’s Disease, Autism and other neurodevelopmental, neurodegenerative and gastrointestinal diseases. Yom Chai has deep experience in the international medical cannabis market Read the full article…

Alternative Health CEO Updates Shareholders On Spinoff Plans

Management has received Board approval to explore a spinoff plan for the Company’s non-cannabis assets,

TEXAS: The CEO of Alternate Health CEO this week provided further details about the company’s spinoff plans and key milestones for the upcoming quarters. “The Company has been very active this year adjusting our business for revenue generation and growth, including developing our potential spinoff plan for Alternate Health’s non-cannabis assets,” says Dr. Michael Murphy, Chairman and Read the full article…

High Park Farms Begins Cannabis Cultivation in Ontario

“British Columbia is known around the world for its rich cannabis culture and the quality of its cannabis genetics”

CANADA: High Park Farms has announced that cannabis cultivation has begun at its state-of-the-art greenhouse in Enniskillen, Ontario following the successful arrival of thousands of live cannabis plants from Nanaimo, British Columbia. The arrival of the plants marks a major milestone for High Park as the company rapidly scales its operations in anticipation of the historic legalization Read the full article…

Medical Cannabis Data Shows Strong Sales And Growth

MMJ reduces opioid use

According to a research published by Hexa Research, the U.S. medical cannabis market size was valued at USD 5.44 billion in 2016, and is expected to be valued $19.48 billion by 2024. The medical cannabis market is still in stage of development and is expected to grow significantly during the forecast period owing to rising consumer demand. Consumer attitude Read the full article…

Research Shows Medical Cannabis To Become a Major Part Of Pharmaceutical Market

Cannabis to make major impact on pharmaceutical marketplace

NEW YORK: According to a research report by New Frontier Data, medical marijuana sales are forecast to grow to $5.3 billion in 2017, accounting for 67% of total cannabis sales. Medical sales in currently legal states are forecast to grow to $13.2 billion by 2025, at which point medical sales will account for 55% of all sales. In comparison, adult-use Read the full article…